Proficio Capital Partners LLC Takes Position in Oracle Corporation $ORCL

Proficio Capital Partners LLC purchased a new stake in shares of Oracle Corporation (NYSE:ORCL) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 7,228 shares of the enterprise software provider’s stock, valued at approximately $1,059,000.

Other hedge funds have also added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Oracle in the fourth quarter worth $4,336,031,000. Bank of New York Mellon Corp purchased a new position in shares of Oracle in the 2nd quarter worth about $1,911,930,000. Capital Research Global Investors increased its position in shares of Oracle by 29.3% during the 4th quarter. Capital Research Global Investors now owns 30,137,126 shares of the enterprise software provider’s stock valued at $5,874,070,000 after purchasing an additional 6,826,299 shares during the last quarter. Cardano Risk Management B.V. lifted its position in Oracle by 882.3% in the 4th quarter. Cardano Risk Management B.V. now owns 4,991,010 shares of the enterprise software provider’s stock worth $972,798,000 after buying an additional 4,482,934 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Oracle in the second quarter worth approximately $625,454,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Trading Down 5.5%

NYSE:ORCL opened at $140.99 on Wednesday. The stock has a market cap of $406.12 billion, a price-to-earnings ratio of 24.18, a PEG ratio of 0.93 and a beta of 1.74. The company’s 50 day moving average price is $139.73 and its 200-day moving average price is $160.44. Oracle Corporation has a 52 week low of $114.50 and a 52 week high of $345.72. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 3.21.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.96 by $0.15. Oracle had a return on equity of 58.62% and a net margin of 25.37%.The firm had revenue of $19.18 billion during the quarter, compared to analysts’ expectations of $19.10 billion. During the same quarter in the previous year, the business earned $1.70 earnings per share. The company’s revenue was up 20.6% on a year-over-year basis. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. On average, equities research analysts forecast that Oracle Corporation will post 6.49 earnings per share for the current fiscal year.

Oracle Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Friday, July 10th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend was Friday, July 10th. Oracle’s dividend payout ratio (DPR) is presently 34.31%.

Insider Transactions at Oracle

In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the completion of the sale, the insider directly owned 400,000 shares of the company’s stock, valued at approximately $63,664,000. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 40.90% of the company’s stock.

Wall Street Analyst Weigh In

ORCL has been the topic of several recent research reports. Mizuho set a $320.00 target price on shares of Oracle in a report on Wednesday, June 3rd. DA Davidson upped their price objective on shares of Oracle from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Thursday, June 11th. TD Cowen dropped their price target on Oracle from $300.00 to $240.00 and set a “buy” rating for the company in a research note on Tuesday. Bank of America raised their price objective on shares of Oracle from $200.00 to $240.00 and gave the stock a “buy” rating in a report on Tuesday, June 9th. Finally, Sanford C. Bernstein boosted their target price on shares of Oracle from $319.00 to $325.00 and gave the company an “outperform” rating in a report on Thursday, June 11th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $262.39.

Trending Headlines about Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle reported $638 billion in remaining performance obligations at fiscal 2026 year-end, up 363% year over year. The backlog provides significant long-term revenue visibility, although management expects only 12% to convert to revenue within the next 12 months. Oracle Has $638 Billion of Contracted Backlog and a $430 Billion Stock
• Positive Sentiment: Analysts continue to point to Oracle’s cloud and AI growth potential. TD Cowen maintained a Buy rating despite reducing its price target to $240, while other commentary described ORCL as potentially undervalued relative to its cloud and AI opportunity. Oracle Slides as Cowen Cuts Target
• Positive Sentiment: Oracle Health expanded its Clinical AI Agent in the United States, adding automation for documentation, coding and chart-review workflows within electronic health records. The rollout could strengthen Oracle’s position in healthcare technology and support its broader AI strategy. Oracle Health Using Healthcare AI
• Neutral Sentiment: Oracle’s next quarterly report is approaching, and analysts expect another earnings beat based on its historical surprise record. Investors will focus on cloud growth, backlog conversion, capital spending and updated financing plans. Why Oracle Is Poised to Beat Earnings Estimates Again
• Negative Sentiment: Fiscal 2026 free cash flow was negative $23.7 billion as Oracle accelerated data-center investment. The company raised $43 billion in debt and expects to raise roughly $40 billion more in fiscal 2027, increasing sensitivity to higher interest rates and execution risk. Why Is Oracle Stock Down Today
• Negative Sentiment: TD Cowen’s target reduction highlighted concerns that spending is arriving before revenue, while a global bond selloff is pressuring highly leveraged AI infrastructure companies. Rising yields reduce the attractiveness of ORCL’s debt-funded expansion and future cash flows. Oracle Falls as Bond Selloff Tests AI Buildout
• Negative Sentiment: EU antitrust regulators are examining Oracle’s licensing practices, according to a Reuters source. A regulatory case similar to SAP’s could create compliance costs, concessions or restrictions on Oracle’s commercial model. Oracle Licensing Practices on EU Antitrust Radar
• Negative Sentiment: Renewed geopolitical tensions, higher global bond yields and broader technology-sector weakness further reduced investor risk appetite, adding pressure to ORCL alongside company-specific balance-sheet concerns. SoundHound AI, Fastly and Oracle Shares Plummet

Oracle Company Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.